Loan Interest Revenue up 31% and Recurring Free Cash Flow up 88% in the yearTORONTO, May 01, 2025 (GLOBE NEWSWIRE) -- Flow Capital Corp. (TSXV:FW), a leading provider of flexible growth capital and alternative debt solutions, announces its unaudited financial and operating results for the for the three-months (Q4 2024) and year ended December 31, 2024. Q4 2024 Performance Highlights 44% increase in Loan Interest Revenue to $2.7 million. 61% increase in Recurring Free Cash Flow to $545,591 $0.018 in Recurr ...

WISeKey Confirms June Launch of Next-Generation WISeSat Satellite with SpaceX Featuring Encrypted Communications and SEALCOIN Integration Geneva, Switzerland, May 1, 2025 –WISeKey International Holding Ltd (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a leading global cybersecurity, blockchain, and IoT company, today announces the upcoming launch of its next-generation WISeSat.Space satellite aboard a SpaceX mission in June 2025. This milestone marks a major technological step forward for WISeSat.Space’s secure s ...

Continued significant investment to improve reliability and transition to cleaner generation; on track to invest $4.4 billion into our utilities in 2025Began operations of Michigan’s largest battery energy storage systemBoosted small businesses with energy efficiency upgrade grantsRecognized as a Gallup Exceptional Workplace for 13th consecutive year DETROIT, May 01, 2025 (GLOBE NEWSWIRE) -- DTE Energy (NYSE: DTE) today reported that it invested over $850 million into its utilities in the first quarter of 2 ...

Meta's content-moderation mishaps used to be the talk of Madison Avenue, when advertisers would lambast the tech giant over its so-called brand safety concerns. But it's a new era, and advertisers are spending through it.The company's first-quarter revenue, which is almost entirely derived from advertising, reached $42 billion in the quarter, ahead of analysts' expectations and up 16% year over year. In January, Meta said it was replacing third-party fact-checkers with an X-inspired community notes system ...

This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility: Credit: CC0 Public Domain Google's ad network has begun showing advertising within the flow of conversations with chatbots—part of Alphabet Inc.'s efforts to keep its edge in digital advertising as generative artificial intelligence takes off. Earlier in 2025, the Google AdSense network, which traditionally displays ads in sea ...

Company Overview - Altisource Portfolio Solutions S.A. reported financial results for Q1 2025, showing a strong performance with service revenue growth of 11% year-over-year to $40.9 million and Adjusted EBITDA growth of 14% to $5.3 million [2][5][6]. Financial Performance - The company achieved its highest quarterly service revenue since Q3 2021, driven by stronger foreclosure starts, sales wins, and the ramp-up of its Renovation business [5][6]. - Adjusted EBITDA margin improved to 12.9%, up from 12.6% in the same quarter of 2024 [5][6]. - The company ended the quarter with $30.8 million in cash and cash equivalents [5][6]. Debt Management - In February 2025, Altisource executed a debt exchange transaction, reducing its senior secured term loans from $232.8 million to a new first lien loan of $160 million, significantly lowering annual interest expenses [5][6][8]. - The debt exchange transaction is expected to reduce annual cash interest expenses by approximately $18 million and GAAP interest expense by $23 million [5][6]. Business Segments - The Servicer and Real Estate and Origination segments improved Adjusted EBITDA to $12.5 million, representing 30.5% of service revenue, up from 29.5% in Q1 2024 [4][5]. - The company generated estimated potential annualized service revenue of $4.7 million for both the Servicer and Real Estate segment and the Origination segment [7]. Industry Context - Industrywide foreclosure initiations increased by 25% year-over-year for the three months ended March 31, 2025, while foreclosure sales decreased by 2% [7]. - Mortgage origination volume saw a slight decline of 1%, with an 11% drop in purchase origination and a 25% increase in refinancing origination [7].

Samuel Smith has a diverse background that includes being lead analyst and Vice President at several highly regarded dividend stock research firms and running his own dividend investing YouTube channel. He is a Professional Engineer and Project Management Professional and holds a B.S. in Civil Engineering & Mathematics from the United States Military Academy at West Point and has a Masters in Engineering from Texas A&M with a focus on applied mathematics and machine learning.Samuel leads the High Yield Inve ...

For a while, it seemed like artificial intelligence (AI) was the hottest topic in the business and investing world. Companies rushed to integrate it into their products and services, investors rushed to pour money into any company dealing with AI, and the media couldn't seem to get enough of it.Many big tech companies are still betting big on AI, and the future looks promising for many of them. However, this year, the AI-fueled stock price growth many of them experienced has cooled down a bit and reversed c ...

Company Overview - Clearside Biomedical, Inc. is a biopharmaceutical company focused on revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS) [3] - The company utilizes a patented SCS Microinjector for an in-office, repeatable, non-surgical procedure aimed at delivering therapies to the macula, retina, or choroid [3] - Clearside is developing a pipeline of small molecule product candidates for administration via its SCS Microinjector, with its lead program, CLS-AX, targeting neovascular age-related macular degeneration (wet AMD) [3] Product Development - The company is planning a Phase 3 program for its lead product, CLS-AX (axitinib injectable suspension) [3] - Clearside is also evaluating various small molecules for potential long-acting treatment of geographic atrophy (GA) [3] - The first product developed by Clearside, XIPERE (triamcinolone acetonide injectable suspension), has been approved for suprachoroidal use and is available in the U.S. through a commercial partner [3] Upcoming Events - Management will participate in a fireside chat at the Citizens Life Sciences Conference on May 7, 2025, at 1:00 p.m. ET [1] - A live and archived webcast of the event will be accessible on the Clearside website under the Investors section, with the archive available for three months [2]

Albert Anthony is a Croatian-American media personality and Analyst for financial media platforms Investing.com and Seeking Alpha, where he has grown over +1K followers since 2023. Writing general markets commentary and opinion as The Analyst, he has covered over +200 companies in multiple sectors, with a focus on dividend stocks. The author grew up in the NYC area and has also called home Austin Texas and his parents' native Croatia, where he took part in many business/innovation conferences as a business ...